Elotuzumab is FDA approved drug for Multiple Myeloma treatment. It was first approved in 2015 This approval was specific to certain patients who have already received one to three prior treatments. Elotuzumab for Relapsed or Refractory Multiple Myeloma is the indication it is advised for. Empliciti has to be given as part of combination therapy. Lenalidomide/Pomalidomide and Dexamethasone are the other two medications used as part of immunotherapy combination. This drug is also approved by the EMA (European Medicines Agency) in 2016. It has further recommended extension of Empliciti indications in 2019.
Is Elotuzumab Chemotherapy?
Elotuzumab is an immunotherapy drug or medicine. Immunotherapy is more advanced than chemotherapy. Even though Empliciti is used in combination of other chemotherapy agents, it is broadly referred as an immunotherapy combination. Immunotherapy drugs work in tandem with the patient’s immune system and produce better outcomes with less or fewer side-effects. The natural killer cells that are also known as NK cells are activated by this drug. NK cells will identify the myeloma cells, target and kill them.
How is Elotuzumab administered?
Empliciti is available in two strengths – 300mg and 400mg. It is an injectable administered through IV route. It has to be infused with the help of an infusion set, administered once in 28 Days. The medication can continue till the disease relapse or when toxicity becomes unacceptable. The product has to be handled by certified clinical pharmacists and administered by nursing professionals trained for immunotherapy infusion. The dosing recommendations and modifications should be under the supervision of a Haematologist. You can visit www.empliciti.com, the official website for more information.
How is Elotuzumab supplied?
Patents can import Elotuzumab in India through Named Patient Access program. This can help you to connect with the authorized global distributors and procure Empliciti. Because it is a cold chain medication, it has to be stored and supplied at 2 to 8 Degree temperature. The logistics play a very vital role in the whole process once your order is finalized. It is important to note this drug is not freely available. It is mostly sourced from the US and European countries, while Germany remains to be the preferred country for sourcing for Indian patients.
Cost of Elotuzumab – Is there any MRP?
Elotuzumab price in India is not guided by the MRP. Empliciti cost is rather determined by many international factors that include foreign currency exchange rates. Your trusted source should help you with optimal cost. But, any compromise on the shipment quality to save the cost can compromise the drug quality. Any specialized medicine imported should serve its purpose.
Who to contact to buy Elotuzumab (Empliciti)?
To buy Empliciti in India, you must engage a reliable source who can help you in all aspects. From helping you with the access information to the shipment advice, you need professional assistance. You may connect with Noel Biotech via email (nhs@noelbiotech.com) or call on +91 9677010046 for more clarity.